<<

Workshop – Zelluläre Therapien

Dienstag, 15. April 2014 Translationszentrum für Regenerative Medizin Seminarraum B1 119/120 (TRM ), Universität Leipzig Philipp-Rosenthal-Straße 55, 04103 Leipzig

Agenda 15:00–15:45 CliniMACS Prodigy® – eine flexible 17:00–17:15 Kaffeepause Plattform zur Zellherstellung 17:15–18:00 Stammzellbasierte Hepatozyten zur Dr. Hans-Dieter Steibl, Therapie bei Lebererkrankungen Clinical Business Manager, Sandra Brückner, TRM Leipzig Miltenyi Biotec, Mesenchymale Stammzellen (CD271+) 15:45–16:00 Kaffeepause zur intraoperativen Herstellung 16:00–16:30 Genetisch modifizierte T-Zellen autologer 3D Knorpeltransplantate in Forschung und Klinik Dr. Matthias Zscharnack, TRM Leipzig Dr. Hermann Bohnenkamp, Prävention immunologischer Business Area Manager, Komplikationen mit erhaltenem Oncology/Infections/Tolerance Antitumoreffekt bei hämatopoetischer Miltenyi Biotec, Bergisch Gladbach Stammzelltransplantation 16:30–17:00 Rechte und Pflichten des Arztes Dr. Stephan Fricke, TRM Leipzig bei der klinischen Translation von Ab 18:00 Get together at the Prodigy – zellulären Therapien Freie Diskussion Dr. Frank Breitkreutz, Fachanwalt Erfrischungen werden serviert. für Medizinrecht und Gewerblichen Rechtsschutz, BBP Rechtsanwälte,

Registrieren Sie sich jetzt unter: Die Organisation erfolgt in Kooperation mit dem Translationszentrum für www.trm.uni-leipzig.de Regenerative Medizin (TRM Leipzig) (Rubrik Veranstaltungen) der Universität Leipzig

miltenyibiotec.com

Miltenyi Biotec GmbH | Phone +49 2204 8306-0 | Fax +49 2204 85197 | [email protected] | www.miltenyibiotec.com

Miltenyi Biotec provides products and services worldwide. Visit www.miltenyibiotec.com/local to find your nearest Miltenyi Biotec contact. Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use. The statements and other contributions presented at the meeting and the views expressed therein are those of the attending experts and do not necessarily represent the policy or opinion of Miltenyi Biotec or any institution the respective expert may be associated with. Neither Miltenyi Biotec nor any of its directors or employees give any representation or warranty as to the reliability, accuracy, or completeness of the content thereof. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient‘s conditions and possible contraindications on dangers in use, review of any applicable manufacturer‘s product information, and comparison with recommendations of other authorities. This document may not be reproduced or distributed in any form in whole or in part without the prior written permission of the authors and Miltenyi Biotec. CliniMACS Prodigy and MACS are registered trademarks of Miltenyi Biotec GmbH. Copyright © 2014 Miltenyi Biotec. All rights reserved.